ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
OphioH327chr_1_162 # 184716 # 184853 # 1 # ID=1_162;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.594	OphioH327chr_1_162 	184716	184853	+	Strict	550	20.7866	VEB-1b	100.0	3003712	protein homolog model	n/a	n/a	monobactam; cephalosporin	antibiotic inactivation	VEB beta-lactamase	ATGCACTTGTGGCGGCGTCTCGCCCTGACGTTTCGTTGCTCACCTCTGACCTCCCCCGGCCCCACTCCGCAGGACCTCCTGCCTCCTTTACTCTGTATTACCTACCACACTGTAGCCCCTCGCCCTTTCCCTAATTAG	MHLWRRLALTFRCSPLTSPGPTPQDLLPPLLCITYHTVAPRPFPN	MKIVKRILLVLLSLFFTVEYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINNDFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTIEQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQNWATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGTSGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK	15.05	gnl|BL_ORD_ID|2068|hsp_num:0	2222	True	loose hit with at least 95 percent identity pushed strict
OphioH327chr_1_235 # 263059 # 263226 # -1 # ID=1_235;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.518	OphioH327chr_1_235 	263059	263226	-	Strict	1000	20.4014	efpA	100.0	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTGCACTTTGCCTCTCGTGTCTCGCTTCTCCCCACGCGCCATTCCCAGATGGGACTATCTGCAGTACTATTCCGCCTGTATCACTGCTGGTCTGCAACCGACCTCCTCTTTTCTGCATCGCATCGTTCTGCACTTGTTAGTGTTCCTTGTCCTTTTGGCCTTCTAA	MCTLPLVSRFSPRAIPRWDYLQYYSACITAGLQPTSSFLHRIVLHLLVFLVLLAF	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	10.38	gnl|BL_ORD_ID|2244|hsp_num:0	2427	True	loose hit with at least 95 percent identity pushed strict
OphioH327chr_1_3040 # 2805352 # 2805705 # -1 # ID=1_3040;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.494	OphioH327chr_1_3040 	2805352	2805705	-	Strict	2000	25.409	Staphylococcus aureus mupA conferring resistance to mupirocin	100.0	3000521	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGCTTTATATTGCCTGTATTTTGCTTGTATTTCGCTTGTATTTTGATTTTATCTCTCTGGTGTATCTTGGCGGCACATCCTCGTCTCGGCCAGCCAACAGTAAGAGAGTGCGCTCTGAGTGCATTTCCACCATCCGCGGCCTCCTGCATCAAGTCCCCCGGGACTGTTCCTGGACCACTACACCCTGGACGCAACTGGAAAAATCAACTGGAAAAATCAACTGGAAAAACGACAAAAAAGTGACGACGGGCCGCCCATCATCTCAGCTAGCCACTAAACAGGCGCTCCAAACGCACCACTCACAGCCGCTGTCAACTCCGGAGCTGTTGTATCTTCTTATTCCTGAGACGTAA	MLYIACILLVFRLYFDFISLVYLGGTSSSRPANSKRVRSECISTIRGLLHQVPRDCSWTTTPWTQLEKSTGKINWKNDKKVTTGRPSSQLATKQALQTHHSQPLSTPELLYLLIPET	MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIGDSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENFVIKNIHLNVIDEYENTIHFNNKEIKISLLY	11.43	gnl|BL_ORD_ID|2125|hsp_num:0	2270	True	loose hit with at least 95 percent identity pushed strict
OphioH327chr_1_6425 # 5906236 # 5906328 # -1 # ID=1_6425;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.591	OphioH327chr_1_6425 	5906236	5906328	-	Strict	2000	20.4014	Staphylococcus aureus mupB conferring resistance to mupirocin	100.0	3000510	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGCTGCTGCGTATAGTCGCCCCTTTCTGCTGGCGCTCTCCTGTCAGAGCCCCTGGCCTGTTTGGCGGCCTGCACATTGTGAGCGAGAAATAA	MLLRIVAPFCWRSPVRAPGLFGGLHIVSEK	MENENIIEEQKILNFWKEENIFKKSIDNRKNDNPFVFYDGPPTANGLPHTGHVLGRVIKDLFARYKTMQGFYVERKAGWDTHGLPVELGVEKKLGIKDKNEIEKYGIEKFINECKNSVFMYEKQWREFSELIGYWVDMEKPYKTMDNTYIESIWYILSDFHKKGLLYKGHKVTPYCPSCETSLSSHEVAQGYKEVKDISVILKFPILDSDENFLVWTTTPWSLPGNIALAINAEEIYVKVNYDNEIFIIMESLLQSVFKDEDNIDIVSKHKGKEFVGKEYLAPFPNKSLMNNENSYKVLPADFVTNKDGTGIVHIAPAYGEDDYKLVQENNIPFINVIDSRGKYNQDSPIFKGELAKESDINIIKELTHLNLLFKKEKYEHSYPFCWRCDNPLIYYAMEGWFIKTTAYKNEIKENNQKIEWYPDHIKNGRFGNFLDNMIDWNIGRKRYWGTPLNIWKCSTCSHEFSPKSINDLIQHSIEDIPSDIELHRPYIDNVKCKCQNCGGDMCREEEVIDVWFDSGSMPFAQNHYPFSGPIQNSYPADFIAEGVDQTRGWFYSLLVISTIFKGEAPYKNALSLGHILDSNGQKMSKSKGNVIDPISMIKTYGADSLRWTLVSDSVPWTNKRFSENMVAQSKSRVIDTLKNIFNFYNMYQKIDNYDYTRDTPKQLNLLDNWAISRMNSVIKEVELHLEKYNPTNASRAIGEFINEISNWYIRRSRSRFWSSEMNEDKKSAYFTLRLILINTCKIIAPFTPFTSEEIHLNLTKKSVHLEDFPQAKEEYINLKLEEDMNKVLDIVEKSRSIRNNINIKTKQPLSNMYIYDNNNLDNEFLRKYKDIIKDEINVKKINIVSDLDNFLEYDVKPNFSTLGPKLGKDMKQFQILFKNIKKEEMNKLINDFDKLQKVFDSLGVTIEEKDFIISKIPKKGFSLSSNDSDRLIILDTNLTQELIREGFVRELIRVIQQLRKQQNFNIEERINVVIDIDSDGLLSIKNNINILKENVLINNLKFEKRETMKYFKINQKEIGIQLMSSFTN	2.90	gnl|BL_ORD_ID|2124|hsp_num:0	2271	True	loose hit with at least 95 percent identity pushed strict
OphioH327chr_2_3784 # 3508154 # 3508678 # -1 # ID=2_3784;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.539	OphioH327chr_2_3784 	3508154	3508678	-	Strict	1050	24.6386	carA	100.0	3002817	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	GTGGTCTCGGAATGTCACAAATGCAAGCCGCCGCTCTTTCAGTCACTCCTGGCCGCCGGCTTTCTGGTAGGCCGACCACTTACAGGCATGCTTCTGGATGTTGGCGGACGCATAAACGTGGCCATTCTCCTGAACATATTCGCAGGTGCTTCGTGCTTGGCGCTCTGGCTTCCATCGCTCTCTTCTGCCCCGGTAGCGGTGTTTGCTCTTGTTCAGGGCTGTACAGGCGGCTCAGTGTGGGCGGCAGCACCAGTGATGGTCGAGATGGTTGGCACCGCACAATCTGGCTCGGCTCTAGCCATGTTCTGGATGCTTGTAGCCCCTTCGGCGGCGTTCTCTAGTCCCTCGGCCATTGGCCTACTTAACTATGCACATAATCATCTGCACAAAGATGGCGCTGAGGCCTATGCAATCTCTATCGGGTTCAGTGGTGGTCTTTTTCTTCTTTCAAGTATTTGCCTTTGTGGTGCAAAAGTTTATCAGATGAGAGTACTAAGGCAAGAACAGACACCCTGGGACAGCTGA	MVSECHKCKPPLFQSLLAAGFLVGRPLTGMLLDVGGRINVAILLNIFAGASCLALWLPSLSSAPVAVFALVQGCTGGSVWAAAPVMVEMVGTAQSGSALAMFWMLVAPSAAFSSPSAIGLLNYAHNHLHKDGAEAYAISIGFSGGLFLLSSICLCGAKVYQMRVLRQEQTPWDS	MSTAQLALHDITKRYQDHVVLDRIGFTIKPGEKVGVIGDNGSGKSTLIKLIAGREQPDNGAVTVVAPGGVGYLAQTLELPLEATVQDAVDLALADLRELEEGMRRTEAELAERPYQTGQDPELAGLLESYAALVDRYQARGGYEADSRVEIALHGLGLPGLERGRRLGTLSGGERSRLALAATLASEPELLLLDEPTNDLDDRAVDWLEEHLRKHKGTVVAVTHDRLFLDRLTTTILEIDSGKVMRYGNGYEGYLAAKAAERQRRLLEYEQWRAELDRSRDLIASNVARLDAIPRKLPFAVFGAGQFRMRGRGHGAMVRIRNAKERVARLTENPVAPPPEPLTFTAEITTEAAQSRETVAELTGVRVGDRLSVDSLHLGPGERLLVTGPNGAGKTTLLRVLSGELEPDSGSLLVSGRVGHLRQEQTPWRPGMTVLQAFSSGRAGDIDEHTEALLSLGLFSPDDLRQRVQDLSYGQRRRIELARLVTEPVDLLLLDEPTNHLSPALVEELEEALTGYQGTVVVVTHDRRMRSRFNGAHLTLQDGRVAEFTAA	31.58	gnl|BL_ORD_ID|873|hsp_num:0	928	True	loose hit with at least 95 percent identity pushed strict
OphioH327chr_2_4514 # 4192286 # 4192486 # -1 # ID=2_4514;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.557	OphioH327chr_2_4514 	4192286	4192486	-	Strict	400	21.557	PEDO-3	100.0	3003715	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	subclass B1 PEDO beta-lactamase	ATGTTCGCCCGCCAAGCTCAAGTGACAATCTTGATGTCATCAGTTAGGCCCGTCATGTCAGTCAGGCCCAGCTACCAGAACAGCCGAGGGCGGTCCGAACGTAACCCTTGCATCACCGGCCACGCAGCATGGATCACGGAGTACACCAGACCACTCTTAAAGGGCATACAGGCACGAAGTACGACTTTGATGGCTGGCTGA	MFARQAQVTILMSSVRPVMSVRPSYQNSRGRSERNPCITGHAAWITEYTRPLLKGIQARSTTLMAG	MRYLLSFLLCLSAFASFAQNPKIKIKHLTGDLYVYTTYNTYKGALTDANAVYLVTNKGVVVIDAPWDATQFQPFLDSIQTKHHQKVVLAIATHSHGDRAGGLAFFKSKGIKTYTNKLTDEILKTNKEPRAAYTFTNDTTFTVGQYKINTYYAGKGHTKDNLVVWFPKDKVLFGGCLIKSIEANDLGYIGESDLAAWPKSIEKLKQKYPDTKIVITGHAAWGNRESLDHTLKLLREKK	27.85	gnl|BL_ORD_ID|2073|hsp_num:0	2230	True	loose hit with at least 95 percent identity pushed strict
OphioH327chr_2_5707 # 5283571 # 5283747 # 1 # ID=2_5707;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.373	OphioH327chr_2_5707 	5283571	5283747	+	Strict	3000	20.7866	abcA	100.0	3003942	protein homolog model	n/a	n/a	cephalosporin; penam; peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGTGTCTGAAACTTTCTGTGTTGCTGACTGTATCTTGTGCTGTTTGCATTGTCTCTATTAAAATAACATGGATTAATCTTTATTCAGATGCTGAAAATGATGCTGCCTACCACACTGTGACTCTTTATATTCTATTATTTGCTGTGACATGGCCACCCTGTCCTCCTAAACTTTGA	MCLKLSVLLTVSCAVCIVSIKITWINLYSDAENDAAYHTVTLYILLFAVTWPPCPPKL	MNESHEAGKNSSTNVEEREEEVLRLARQFTEQSSYSTAGQTPFAAEAGSALDPNGERFNARAWCKAMLQMHIGDKEAHPLRTLGVAFSNLNVHGFGSDTDYQKSVGNVWLKTLSLARIAFGQKQRKVDILQNLEGLVEAGEMLVVLGPPGSGCSTFLKTIAGETYGFHVDKNSNINFQGIAKQMAHEFRGEAIYTAEVDVHFPKLTVGDTLYFAARARTPRHIPGGVNATQYAGHMRDVIMAMFGISHTKNTIVGNDFIRGVSGGERKRVSIAEACLSNAPLQCWDNSTRGLDSANAIEFCKTLRMQADINGTTACVSLYQAPQAAYDYFDKVLVLYEGREIYFGPTSMAKHYFLQMGFVCPDRQTDADFLTSMTSHLERVVQPGYEDRVPRTPDEFAARWKASPQRAQLMQHIKSYNAKFALDGEYLDKFKQSRRAQQAKAQRVSSPYTLSYVQQVKLCLWRGYQRLKADPSVTISSLFGNTIISLVIASIFYNLKADTSTFFQRGALLFFAVLMNALGCGLEMLTLYAQRGIIEKHSRYALYHPSAEAFSSMIMDLPYKILNAITSNIVLYFMTNLRREPGAFFFFVFTSFILTLTMSMFFRSMASLSRSLVQVLPFSAVLLLGLSMYTGFAIPTGYMLGWARWIAYINPISYGFESLMINEFHNRDFPCMDYVPSGPGYTDVGLNNRVCSTVRSVPGQAFVNGNAYIESAYSYTASHKWRNIGVIFAYMFLLGAVYLVATDFITEKKPKGEILVFPRGHKALKKGKSDEDLEGGGGRSATVEKIGSDGLAMIERQTAIFQWKDVCFDIKIGKENCRILDHVDGWVKPGILTALMGVSGAGKTTLLDVLATRTTMGIISGEMLVDGQPRDESFQRKTGYAQQQDLHLSTATVREALEFSALLRQSAHVPRQEKIDYVTEVIKLLDMTEYADAVIGVPGEGLNVEQRKRLTIGVELAARPQLLLFLDEPTSGLDSQTSWAILDLLDKLKKNGQAILCTIHQPSAMLFQRFDRLLFLQAGGRTVYFGEIGQNSQILIDYFVRNGAPPCPPDANPAEWMLDVIGAAPGSHTSINWFETWRRSPEYARVQEHLAELKHERRHQTNLFRTTSGQKREDKDSYREFAAPFWAQLYQVQVRVFQQIWRSPTYIYSKTALCVLSALFVGFSLFHTPNTIQGLQNQMFGIFMLLTLFGQLIQQIMPHFVAQRALYEVRDRPAKTYSWKAFLIANIVVELPWNSLMSVLMFLCWYYPIGLYRNAEPTDAVHLRGTQMWLMIWTFLLFSSTFAHFMIAAFDAAENAGNLGNLLFLLCLLFCGVLATPDQLPRFWIFMYRVSPFTYLVSGMLSVGISNTNVTCADNEYLRFDPVNGTCGEYMGSYMSNLGGYLADEMATANCSFCPIKETNVFLGRVSSSYSDIWRNFGLMWVFIVFNIFAACSLYWWVRVPRDKKPVAKAE	3.99	gnl|BL_ORD_ID|2224|hsp_num:0	2416	True	loose hit with at least 95 percent identity pushed strict
OphioH327chr_3_1404 # 1301442 # 1301660 # 1 # ID=3_1404;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.493	OphioH327chr_3_1404 	1301442	1301660	+	Strict	400	21.1718	ErmG	100.0	3000522	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCGCCGAACCAATCGCTGCTACTCTAATTTCTGGGGTACACTGCATATCCCAGCTAGTCATAATCCCTACAAAATCCATACAAAATCGCTGCTAAAGAAATCGATTGCCGTATGGCGTATCCTTTGCCTCGTGTTGTCATGGCCATTTTTGCGCCGTATTGCTAGACCGACGGCCGCTTGCCGGCGCATGCATGCTAATTTGGGCGTGCTTTGTTAG	MRRTNRCYSNFWGTLHIPASHNPYKIHTKSLLKKSIAVWRILCLVLSWPFLRRIARPTAACRRMHANLGVLC	MNKVNIKDSQNFITSKYHIEKIMNCISLDEKDNIFEIGAGKGHFTAELVKRCNFVTAIEIDSKLCEVTRNKLLNYPNYQIVNDDILKFTFPSHNPYKIFGSIPYNISTNIIRKIVFESSATISYLIVEYGFAKMLLDTNRSLALLLMAEVDISILAKIPRYYFHPKPKVDSTLIVLKRKPAKMAFKERKKYETFVMKWVNKEYEKLFTKNQFNKALKHARIYDINNISFEQFVSLFNSYKIFNG	29.51	gnl|BL_ORD_ID|935|hsp_num:0	989	True	loose hit with at least 95 percent identity pushed strict
OphioH327chr_5_200 # 218879 # 218974 # 1 # ID=5_200;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.427	OphioH327chr_5_200 	218879	218974	+	Strict	675	20.4014	emrA	100.0	3000027	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTTCTTGTTTCTTGTTCTTGTTACTCTAGATCCCACACCCTACATGCACTCTAATACGGCGTACACCCTGCAACGTTTGTCACTCTTACATTAG	MFLFLVLVTLDPTPYMHSNTAYTLQRLSLLH	MSANAETQTPQQPVKKSGKRKRLLLLLTLLFIIIAVAIGIYWFLVLRHFEETDDAYVAGNQIQIMSQVSGSVTKVWADNTDFVKEGDVLVTLDPTDARQAFEKAKTALASSVRQTHQLMINSKQLQANIEVQKIALAKAQSDYNRRVPLGNANLIGREELQHARDAVTSAQAQLDVAIQQYNANQAMILGTKLEDQPAVQQAATEVRNAWLALERTRIISPMTGYVSRRAVQPGAQISPTTPLMAVVPATNMWVDANFKETQIANMRIGQPVTITTDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDQKQLEQYPLRIGLSTLVSVNTTNRDGQVLANKVRSTPVAVSTAREISLAPVNKLIDDIVKANAG	7.95	gnl|BL_ORD_ID|1656|hsp_num:0	1757	True	loose hit with at least 95 percent identity pushed strict
OphioH327chr_5_2030 # 1951178 # 1951393 # 1 # ID=5_2030;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.477	OphioH327chr_5_2030 	1951178	1951393	+	Strict	600	21.9422	vanHO	100.0	3002948	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGTCGTCTGAAAACATCTCGAGAGGCTTTTCTATGCCGGTCAGCCTGGTCAATTGCTTGAATTTCTTGCAATCGCCAAAGTTTTGGATGGTCCTATTTTGGATTGTCTGGTATGTTTTTGCCCCATATCTCATATCCCACGTCCCATGGCCCATGGTCGATGGTCCATGCTCCCCTCACTGCAATCTGCAGATTATAGCCGGCCTGGCATACTAA	MSSENISRGFSMPVSLVNCLNFLQSPKFWMVLFWIVWYVFAPYLISHVPWPMVDGPCSPHCNLQIIAGLAY	MSYRDLGLIDSEVIAERRVRALDDSSPSAVPTTGVRVFGCGHDEAVLFREMGTRLGITPSITEEAISETNAELARGNRCISVSHKTQIDNSTLLALSRVGVEYISTRSVGYNHIDVEFAASIGISVGNVDYSPDSVGDYTLMLMLMTVRHAKSIVRRADTHDYRLNDTRGRELRDLTVGVIGTGRIGTAVIDRLQGFGCRVLAHDSGPHASADYVPLDELLRQSDIVTLHTPLTADTHHLLDRQRIDQMKHGAYIVNTGRGPLLDTEALLSALESGRLGGAALDVVEGEEGIFYADCRNRLIENKALVRLQRLPNVLISPHSAYYTDHALNDTVENSLVNCLNFESGRTA	20.29	gnl|BL_ORD_ID|741|hsp_num:0	786	True	loose hit with at least 95 percent identity pushed strict
OphioH327chr_7_1273 # 1288020 # 1288202 # 1 # ID=7_1273;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.525	OphioH327chr_7_1273 	1288020	1288202	+	Strict	500	22.3274	FIM-1	100.0	3004786	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	FIM beta-lactamase	ATGTGGGGCCAGTCCAAAAACGTTGCTCCCAGCCTTGACGAGCACGATCTAATTTTCGACTCAGGTCGGGGGCTGCTATTCAGGGCGTTGCTACACTTCAGGGAGCGCATCTACTCCATCGTCCACGACACGTATCATCACATCTACACAACACGATATAGCAGGACGATGCAGAGCTGCTAA	MWGQSKNVAPSLDEHDLIFDSGRGLLFRALLHFRERIYSIVHDTYHHIYTTRYSRTMQSC	MRPLPHSYLKSLVICLLTAFAALTPVVNSGVQAAQPKDVPVTFTAITQGVWMHTSMKHMENWGHVPSNGLIVEKGDFSILVDTAWDDPQTAQIIEWSKDTLKKPIRWAVFTHAHDDKMGGVAALRQQGIVTYAAADSNRMAPQNGLTPAEHDLIFDSEHSTSVLHPLVIFDPGPGHTRDNIVVGLPEQGIVFGGCLIRPSGSTSLGNTADADLAHWKTAVLAVAQRFAEAQQIIPSHGPMAGRELFELTAQLAEKASIPSTP	22.90	gnl|BL_ORD_ID|2230|hsp_num:0	3584	True	loose hit with at least 95 percent identity pushed strict
OphioH327chr_7_1782 # 1746426 # 1746848 # 1 # ID=7_1782;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.624	OphioH327chr_7_1782 	1746426	1746848	+	Strict	1800	23.483	MexD	100.0	3000801	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGGGCATGCCGGGAACCGGTGATGGGCCGGGACCTGCGGAGCCGAAGCACAGCCAAAAGTGCGGGCACCAATGCGGGCATCCACTGGTTGCAGAGGTGTTGGCGCCAGCTGCCGCCGGGAGCTTCGCGTGTCTTGATATCCCTCCATGCAGCCTCGACCACATCGCATCACGAGATATGCCTCAGCCACCTCGATATACCTCACATCACCTCACCTCACCTGATGTCCTCCTTCACATATACACGTCCACATGCTAACAGACAGCTTACTGGATCTCTTTCGGTCCCCACGGCCCCCGCTCCGAGCCCCCTGCCGGCGAGGGCAAGAAGGTCGCCCTCTACACTGCCATTGGTGTCGGCGCGTCGCTGCTCGTCTTCAGCTCTATGCGCCTGTTCGCCGGCGGCGCTCCCCCGACAATGA	MGACREPVMGRDLRSRSTAKSAGTNAGIHWLQRCWRQLPPGASRVLISLHAASTTSHHEICLSHLDIPHITSPHLMSSFTYTRPHANRQLTGSLSVPTAPAPSPLPARARRSPSTLPLVSARRCSSSALCACSPAALPRQ	MSEFFIKRPNFAWVVALFISLGGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDSVTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQAVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNINNELRRLPGVGKLQFFSSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKGTLDDPQEFGQVVLRANEDGSLVPARRCRAPGTRQGELQHFLATERHAHRGRGYPAVARGQRDPDPTLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLFLENVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVERIMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSILFSGFLALTFTPALCATLFKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVARAGRFMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERFLKSREAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSSAAEIAALNEHFALPDDGTVMAVSPPPINGLGNSGGFALRLMDRSGVGREALLQARDTLLGEIQTNPKFLYAMMEGLAEAPQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRMTPESVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEMERLASQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSVMLIVPIGAIGAVLAVMVSGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRDAAIEAARLRFRPIIMTSMAFILGVIPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPICFVWLLSLLRSKPAPIEQAASAGE	13.42	gnl|BL_ORD_ID|1525|hsp_num:0	1523	True	loose hit with at least 95 percent identity pushed strict
OphioH327chr_8_49 # 87590 # 87742 # 1 # ID=8_49;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.510	OphioH327chr_8_49 	87590	87742	+	Strict	2300	23.483	evgS	100.0	3000833	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGAACATGTTCTTTCAACAGCGAGCCTATTCAGCGTCAAGGGGTACGTCGCGGTCGTCACGGGAGGCAGCAGTGGCCTTGGGTTGATGATCTGCAAGGTAAGTTTGTTCAACGCTGTCGTCAGCCTCACAGGCAGCCATATACTTATTTAA	MEHVLSTASLFSVKGYVAVVTGGSSGLGLMICKVSLFNAVVSLTGSHILI	MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDIVLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSPGGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVPNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND	4.18	gnl|BL_ORD_ID|1243|hsp_num:0	1318	True	loose hit with at least 95 percent identity pushed strict
